Specific Antiseizure Medications Associated With Major Malformations in Infants
By Elana Gotkine HealthDay Reporter
FRIDAY, July 18, 2025 -- Maternal use of valproate, phenobarbital, and topiramate early in pregnancy is associated with an increased risk for major malformations in infants compared with lamotrigine, according to a study published online July 16 in Neurology.
Sonia Hernandez-Diaz, M.D., Dr.P.H., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues quantified the relative risk for major malformations in offspring after maternal use of specific antiseizure medications (ASMs) early in pregnancy, with special interest in second-generation ASMs, among pregnant women enrolled in the North American Antiepileptic Drug Pregnancy Registry between 1997 and 2023.
The analysis included 7,311 participants taking an ASM as monotherapy during the first trimester (mean age, 30 years). The researchers found that the risk for major malformations was 2.1, 2.0, 2.8, 5.1, 2.8, 9.2, 1.5, 1.5, 1.3, 6.0, 3.2, and 0 percent for lamotrigine, levetiracetam, carbamazepine, topiramate, phenytoin, valproate, oxcarbazepine, gabapentin, zonisamide, phenobarbital, pregabalin, and lacosamide, respectively. The risk ratio was 5.1, 2.9, and 2.2 for valproate, phenobarbital, and topiramate, respectively, compared with lamotrigine. There was a specific association seen for topiramate with a higher risk for cleft lip.
"Our study looked at a number of drugs and provides valuable information for health care providers and people who may become pregnant to make more informed decisions about the use of these medications during pregnancy," Hernandez-Diaz said in a statement.
Two authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
One in 60 Women Undergoing C-Section Experience Severe Perioperative Morbidity
TUESDAY, Sept. 2, 2025 -- Nearly one in 60 patients undergoing cesarean delivery experiences severe perioperative surgical morbidity, according to a study published online Aug. 21...
2010 to 2023 Saw Decline in Births, Increase in Deaths in the United States
FRIDAY, Aug. 29, 2025 -- From 2010 to 2023, the number of births in the United States declined, and the number of deaths increased, according to the Aug. 27 National Vital...
Treatment Response to Antiseizure Medications Can Take More Than One Year
WEDNESDAY, Aug. 27, 2025 -- Many people with newly diagnosed focal episodes take more than one year and more than one antiseizure medication (ASM) to become seizure-free...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.